Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yozo Sato

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2011
Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancerKohei Shitara, Takashi Ura, Keitaro Matsuo, et al.
Internal Medicine (Tokyo, Japan)|August 14, 2018
Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary TherapyHiroki Tanaka, Susumu Hijioka, Hiromichi Iwaya, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 17, 2021
Clinical characteristics of Japanese patients with moderate to severe COVID-19Ryota Otoshi, Eri Hagiwara, Takaaki Kitayama, et al.
Respiratory Investigation|May 9, 2021
Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019Takafumi Yamaya, Eri Hagiwara, Tomohisa Baba, et al.
BMC Cancer|March 12, 2025
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinomaYoshihisa Kodama, Kazuomi Ueshima, Michihisa Moriguchi, et al.
Respiratory Investigation|September 7, 2020
Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 casesKota Murohashi, Eri Hagiwara, Takaaki Kitayama, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2011
Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancerKohei Shitara, Takashi Ura, Keitaro Matsuo, et al.
Internal Medicine (Tokyo, Japan)|August 14, 2018
Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary TherapyHiroki Tanaka, Susumu Hijioka, Hiromichi Iwaya, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 17, 2021
Clinical characteristics of Japanese patients with moderate to severe COVID-19Ryota Otoshi, Eri Hagiwara, Takaaki Kitayama, et al.
Respiratory Investigation|May 9, 2021
Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019Takafumi Yamaya, Eri Hagiwara, Tomohisa Baba, et al.
BMC Cancer|March 12, 2025
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinomaYoshihisa Kodama, Kazuomi Ueshima, Michihisa Moriguchi, et al.
Respiratory Investigation|September 7, 2020
Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 casesKota Murohashi, Eri Hagiwara, Takaaki Kitayama, et al.
Pageof 11